Pharmacological and genetic studies over the past decade have established the follicle-stimulating hormone (FSH) as an actionable target for diseases affecting millions, namely osteoporosis, obesity, and Alzheimer’s disease. The gene discussed is BRD2; the disease is early-onset autosomal dominant Alzheimer disease.